Back to Search Start Over

Comparison of optical coherence tomography–guided versus intravascular ultrasound–guided percutaneous coronary intervention: Rationale and design of a randomized, controlled OCTIVUS trial

Authors :
Soo-Jin Kang
Seung Ho Hur
Hanbit Park
Seong-Wook Park
Sang Wook Kim
Cheol Hyun Lee
Seung-Jung Park
Do-Yoon Kang
Young-Hak Kim
Seung-Whan Lee
Jung-Min Ahn
Soon Jun Hong
Jun-Hyok Oh
Yun-Kyeong Cho
Jang Ho Bae
Duk-Woo Park
Young Joon Hong
Soo-Joong Kim
Pil Hyung Lee
Young Won Yoon
Source :
American Heart Journal. 228:72-80
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Background The clinical value of intracoronary imaging for percutaneous coronary intervention (PCI) guidance is well acknowledged. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are the most commonly used intravascular imaging to guide and optimize PCI in day-to-day practice. However, the comparative effectiveness of IVUS-guided versus OCT-guided PCI with respect to clinical end points remains unknown. Methods and design The OCTIVUS study is a prospective, multicenter, open-label, parallel-arm, randomized trial comparing the effectiveness of 2 imaging-guided strategies in patients with stable angina or acute coronary syndromes undergoing PCI in Korea. A total of 2,000 patients are randomly assigned in a 1:1 ratio to either an OCT-guided PCI strategy or an IVUS-guided PCI strategy. The trial uses a pragmatic comparative effectiveness design with inclusion criteria designed to capture a broad range of real-world patients with diverse clinical and anatomical features. PCI optimization criteria are predefined using a common algorithm for online OCT or IVUS. The primary end point, which was tested for both noninferiority (margin, 3.1 percentage points for the risk difference) and superiority, is target-vessel failure (cardiac death, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization) at 1 year. Results Up to the end of July 2020, approximately 1,200 "real-world" PCI patients have been randomly enrolled over 2 years. Enrollment is expected to be completed around the midterm of 2021, and primary results will be available by late 2022 or early 2023. Conclusion This large-scale, multicenter, pragmatic-design clinical trial will provide valuable clinical evidence on the relative efficacy and safety of OCT-guided versus IVUS-guided PCI strategies in a broad population of patients undergoing PCI in the daily clinical practice.

Details

ISSN :
00028703
Volume :
228
Database :
OpenAIRE
Journal :
American Heart Journal
Accession number :
edsair.doi.dedup.....02ba76b0f830bb45db2e6422df9ef277